Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Vasculitis | Research article

Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study

Authors: Peng-cheng Xu, Tong Chen, Si-jing Wu, Xia Yang, Shan Gao, Shui-yi Hu, Li Wei, Tie-kun Yan

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Many patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) need dialysis at disease onset due to severe kidney injury. Determining whether they can become dialysis independent is an important clinical assessment.

Methods

Forty kidney biopsy-proved myeloperoxidase (MPO)-ANCA associated AAV patients who required dialysis at disease onset were enrolled. Relationships between laboratory and pathological characteristics and prognoses were analyzed.

Results

Twenty-five patients obtained dialysis independence within 3 months, while the other 15 patients remained dialysis dependent. No sclerotic class was identified among the 40 patients. Only two biopsies exhibited focal class diagnoses and both these patients recovered their renal function. The renal recovery rate of the 20 patients with mixed class was significantly lower than that of the 18 patients with crescentic class (40.0% vs. 83.3%, p = 0.006). Receiver operating characteristics (ROC) curves showed fibrous crescent+global glomerulosclerosis greater than 32.6% was a strong predictor of dialysis dependence with a sensitivity of 93.3% and specificity of 88.0%. When the percentage of fibrous crescent+global glomerulosclerosis exceeded 47.9%, dialysis independence was not possible. Correlation analysis indicated that platelet counts were negatively correlated with the percentage of fibrous crescent+global glomerulosclerosis (R = -0.448, p = 0.004). Most patients with increased platelets (84.62%) obtained renal recovery. Compared with methylprednisolone pulse therapy, plasma exchange accelerated renal recovery (29.4 ± 15.6 vs. 41.4 ± 11.7 days, p = 0.039).

Conclusions

For MPO-ANCA AAV who required dialysis at disease onset, crescentic and mixed classes accounted for the majority of patients in our cohort. The renal outcome of mixed class patients was worse than that of crescentic class. A high proportion of fibrous crescent+global glomerulosclerosis is a predictor of dialysis dependence. Increased platelet count is associated with active and reversible renal lesions.
Literature
1.
go back to reference Tang W, Bose B, McDonald SP, et al. The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand. Clin J Am Soc Nephrol. 2013;8:773–80.CrossRef Tang W, Bose B, McDonald SP, et al. The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand. Clin J Am Soc Nephrol. 2013;8:773–80.CrossRef
2.
go back to reference Romeu M, Couchoud C, Delaroziere JC, et al. Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011. QJM. 2014;107:545–55.CrossRef Romeu M, Couchoud C, Delaroziere JC, et al. Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011. QJM. 2014;107:545–55.CrossRef
3.
go back to reference Kallenberg CG. Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol. 2014;10:484–93.CrossRef Kallenberg CG. Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol. 2014;10:484–93.CrossRef
4.
go back to reference Sinico RA, Di Toma L, Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev. 2013;12:477–82.CrossRef Sinico RA, Di Toma L, Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev. 2013;12:477–82.CrossRef
5.
go back to reference Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41:776–84.CrossRef Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41:776–84.CrossRef
6.
go back to reference Shi YY, Li ZY, Zhao MH, et al. The CD4 lymphocyte count is a better predictor of overall infection than the Total lymphocyte count in ANCA-associated Vasculitis under a corticosteroid and cyclophosphamide regimen: a retrospective cohort. Medicine (Baltimore). 2015;94:e843.CrossRef Shi YY, Li ZY, Zhao MH, et al. The CD4 lymphocyte count is a better predictor of overall infection than the Total lymphocyte count in ANCA-associated Vasculitis under a corticosteroid and cyclophosphamide regimen: a retrospective cohort. Medicine (Baltimore). 2015;94:e843.CrossRef
7.
go back to reference Jayne DR, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18:2180–8.CrossRef Jayne DR, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18:2180–8.CrossRef
8.
go back to reference Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21:1628–36.CrossRef Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21:1628–36.CrossRef
9.
go back to reference Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11.CrossRef Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11.CrossRef
10.
go back to reference Xu PC, Chen T, Gao S, et al. Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria. Ren Fail. 2018;40:554–60.CrossRef Xu PC, Chen T, Gao S, et al. Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria. Ren Fail. 2018;40:554–60.CrossRef
11.
go back to reference Li ZY, Gou SJ, Chen M, et al. Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center. Semin Arthritis Rheum. 2013;42:515–21.CrossRef Li ZY, Gou SJ, Chen M, et al. Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center. Semin Arthritis Rheum. 2013;42:515–21.CrossRef
12.
go back to reference Ma TT, Liu YR, Chen M, et al. Late restoration of renal function in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation. Clin Rheumatol. 2018;37:2143–50.CrossRef Ma TT, Liu YR, Chen M, et al. Late restoration of renal function in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation. Clin Rheumatol. 2018;37:2143–50.CrossRef
13.
go back to reference Gharbi C, Bourry E, Rouvier P, et al. Rapidly progressive lupus nephritis and concomitant thrombotic microangiopathy. Clin Exp Nephrol. 2010;14:487–91.CrossRef Gharbi C, Bourry E, Rouvier P, et al. Rapidly progressive lupus nephritis and concomitant thrombotic microangiopathy. Clin Exp Nephrol. 2010;14:487–91.CrossRef
14.
go back to reference Zhao J, Yang R, Cui Z, et al. Characteristics and outcome of Chinese patients with both antineutrophil cytoplasmic antibody and antiglomerular basement membrane antibodies. Nephron Clin Pract. 2007;107:c56–62.CrossRef Zhao J, Yang R, Cui Z, et al. Characteristics and outcome of Chinese patients with both antineutrophil cytoplasmic antibody and antiglomerular basement membrane antibodies. Nephron Clin Pract. 2007;107:c56–62.CrossRef
15.
go back to reference Cui Z, Zhao MH, Xin G, et al. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease. Nephron Clin Pract. 2005;99:c49–55.CrossRef Cui Z, Zhao MH, Xin G, et al. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease. Nephron Clin Pract. 2005;99:c49–55.CrossRef
16.
go back to reference Chang DY, Wu LH, Liu G, et al. Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant. 2012;27:2343–9.CrossRef Chang DY, Wu LH, Liu G, et al. Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant. 2012;27:2343–9.CrossRef
17.
go back to reference Córdova-Sánchez BM, Mejía-Vilet JM, Morales-Buenrostro LE, et al. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement. Clin Rheumatol. 2016;35:1805–16.CrossRef Córdova-Sánchez BM, Mejía-Vilet JM, Morales-Buenrostro LE, et al. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement. Clin Rheumatol. 2016;35:1805–16.CrossRef
18.
go back to reference Ellis CL, Manno RL, Havill JP, et al. Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome. BMC Nephrol. 2013;14:210.CrossRef Ellis CL, Manno RL, Havill JP, et al. Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome. BMC Nephrol. 2013;14:210.CrossRef
19.
go back to reference Hilhorst M, Wilde B, van Breda Vriesman P, et al. Estimating renal survival using the ANCA-associated GN classification. J Am Soc Nephrol. 2013;24:1371–5.CrossRef Hilhorst M, Wilde B, van Breda Vriesman P, et al. Estimating renal survival using the ANCA-associated GN classification. J Am Soc Nephrol. 2013;24:1371–5.CrossRef
20.
go back to reference Iwakiri T, Fujimoto S, Kitagawa K, et al. Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. BMC Nephrol. 2013;14:125.CrossRef Iwakiri T, Fujimoto S, Kitagawa K, et al. Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. BMC Nephrol. 2013;14:125.CrossRef
21.
go back to reference Kristensen T, Gregersen JW, Krag SR, et al. The relation between histopathological classification and renal outcome, ANCA subtype and treatment regimens in ANCA-associated vasculitis. Clin Exp Rheumatol. 2016;34:S105–10.PubMed Kristensen T, Gregersen JW, Krag SR, et al. The relation between histopathological classification and renal outcome, ANCA subtype and treatment regimens in ANCA-associated vasculitis. Clin Exp Rheumatol. 2016;34:S105–10.PubMed
22.
go back to reference Moroni G, Binda V, Leoni A, et al. Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopatological classification schema and review of the literature. Clin Exp Rheumatol. 2015;33:S–56-63.PubMed Moroni G, Binda V, Leoni A, et al. Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopatological classification schema and review of the literature. Clin Exp Rheumatol. 2015;33:S–56-63.PubMed
23.
go back to reference Muso E, Endo T, Itabashi M, et al. Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts. Clin Exp Nephrol. 2013;17:659–62.CrossRef Muso E, Endo T, Itabashi M, et al. Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts. Clin Exp Nephrol. 2013;17:659–62.CrossRef
24.
go back to reference Naidu GS, Sharma A, Nada R, et al. Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome. Rheumatol Int. 2014;34:1721–7.CrossRef Naidu GS, Sharma A, Nada R, et al. Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome. Rheumatol Int. 2014;34:1721–7.CrossRef
25.
go back to reference Nohr E, Girard L, James M, et al. Validation of a histopathologic classification scheme for antineutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol. 2014;45:1423–9.CrossRef Nohr E, Girard L, James M, et al. Validation of a histopathologic classification scheme for antineutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol. 2014;45:1423–9.CrossRef
26.
go back to reference Quintana LF, Peréz NS, De Sousa E, et al. ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol Dial Transplant. 2014;29:1764–9.CrossRef Quintana LF, Peréz NS, De Sousa E, et al. ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol Dial Transplant. 2014;29:1764–9.CrossRef
27.
go back to reference Tanna A, Guarino L, Tam FW, et al. Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant. 2015;30:1185–92.CrossRef Tanna A, Guarino L, Tam FW, et al. Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant. 2015;30:1185–92.CrossRef
28.
go back to reference Togashi M, Komatsuda A, Nara M, et al. Validation of the 2010 histopathological classification of ANCA-associated glomerulonephritis in a Japanese single-center cohort. Mod Rheumatol. 2014;24:300–3.CrossRef Togashi M, Komatsuda A, Nara M, et al. Validation of the 2010 histopathological classification of ANCA-associated glomerulonephritis in a Japanese single-center cohort. Mod Rheumatol. 2014;24:300–3.CrossRef
29.
go back to reference Bjørneklett R, Sriskandarajah S, Bostad L. Prognostic value of histologic classification of ANCA-associated glomerulonephritis. Clin J Am Soc Nephrol. 2016;11:2159–67.CrossRef Bjørneklett R, Sriskandarajah S, Bostad L. Prognostic value of histologic classification of ANCA-associated glomerulonephritis. Clin J Am Soc Nephrol. 2016;11:2159–67.CrossRef
30.
go back to reference Westman KW, Bygren PG, Olsson H, et al. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol. 1998;9:842–52.PubMed Westman KW, Bygren PG, Olsson H, et al. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol. 1998;9:842–52.PubMed
31.
go back to reference Chen Y, Bao H, Liu Z, et al. Risk factors for renal survival in Chinese patients with myeloperoxidase-ANCA-associated GN. Clin J Am Soc Nephrol. 2017;12:417–25.CrossRef Chen Y, Bao H, Liu Z, et al. Risk factors for renal survival in Chinese patients with myeloperoxidase-ANCA-associated GN. Clin J Am Soc Nephrol. 2017;12:417–25.CrossRef
32.
go back to reference Willeke P, Kumpers P, Schluter B, et al. Platelet counts as a biomarker in ANCA-associated vasculitis. Scand J Rheumatol. 2015;44:302–8.CrossRef Willeke P, Kumpers P, Schluter B, et al. Platelet counts as a biomarker in ANCA-associated vasculitis. Scand J Rheumatol. 2015;44:302–8.CrossRef
33.
go back to reference Miao D, Li DY, Chen M, et al. Platelets are activated in ANCA-associated vasculitis via thrombin-PARs pathway and can activate the alternative complement pathway. Arthritis Res Ther. 2017;19:252.CrossRef Miao D, Li DY, Chen M, et al. Platelets are activated in ANCA-associated vasculitis via thrombin-PARs pathway and can activate the alternative complement pathway. Arthritis Res Ther. 2017;19:252.CrossRef
34.
go back to reference Chen SF, Wang FM, Li ZY, et al. Complement factor H inhibits anti-neutrophil cytoplasmic autoantibody-induced neutrophil activation by interacting with neutrophils. Front Immunol. 2018;9:559.CrossRef Chen SF, Wang FM, Li ZY, et al. Complement factor H inhibits anti-neutrophil cytoplasmic autoantibody-induced neutrophil activation by interacting with neutrophils. Front Immunol. 2018;9:559.CrossRef
35.
go back to reference Miao D, Ma TT, Chen M, et al. Platelets release proinflammatory microparticles in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford). 2019; Epub ahead of print. Miao D, Ma TT, Chen M, et al. Platelets release proinflammatory microparticles in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford). 2019; Epub ahead of print.
Metadata
Title
Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study
Authors
Peng-cheng Xu
Tong Chen
Si-jing Wu
Xia Yang
Shan Gao
Shui-yi Hu
Li Wei
Tie-kun Yan
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1487-7

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue